BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28629662)

  • 21. Current And Emerging Trends In The Management Of Pyoderma Gangrenosum: A Literature Review.
    Muhammad SW; Hassan N; Khan S; Gohar A
    J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S774-S784. PubMed ID: 38406909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child.
    Kawabe S; Iwata N; Nishida E; Kohagura T; Abe N; Nakaseko H; Morita A
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):137-140. PubMed ID: 33016252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
    Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
    Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyoderma gangrenosum following breast reconstruction.
    MacKenzie D; Moiemen N; Frame JD
    Br J Plast Surg; 2000 Jul; 53(5):441-3. PubMed ID: 10876288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comprehensive Review of Local Pharmacologic Therapy for Pyoderma Gangrenosum.
    Baltazar D; Haag C; Gupta AS; Marzano AM; Ortega Loayza AG
    Wounds; 2019 Jun; 31(6):151-157. PubMed ID: 31215868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penile pyoderma gangrenousm treated with cyclosporine: Case report.
    AlTaleb R; Alajlan A
    J Pak Med Assoc; 2018 Jul; 68(7):1148-1150. PubMed ID: 30317330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment options for pyoderma gangrenosum.
    Quist SR; Kraas L
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):34-40. PubMed ID: 28140549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature.
    Lamet S; Bracke A; Geluykens E; Vlieghe E; Seymons K; Gadisseur AP; Vrelust I; Van Marck V; Somville J; Lambert J
    Acta Clin Belg; 2010; 65(1):37-40. PubMed ID: 20373596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)].
    Petering H; Kiehl P; Breuer C; Kapp A; Werfel T
    Hautarzt; 2001 Jan; 52(1):47-50. PubMed ID: 11220239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pyoderma gangrenosum and Sweet's syndrome : Cutaneous manifestations of autoinflammatory disorders].
    Meier B; Maul JT; French LE
    Hautarzt; 2016 Dec; 67(12):934-939. PubMed ID: 27796411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyoderma gangrenosum and orbital pseudotumor].
    Welzel C; Bloching M; Born S; Berghaus A
    HNO; 2003 Jun; 51(6):486-91. PubMed ID: 12858856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum.
    Tamir A; Landau M; Brenner S
    Dermatology; 1996; 192(3):252-4. PubMed ID: 8726641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyoderma Gangrenosum: Treatment Options.
    Dissemond J; Marzano AV; Hampton PJ; Ortega-Loayza AG
    Drugs; 2023 Sep; 83(14):1255-1267. PubMed ID: 37610614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
    Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
    J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
    Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory pyoderma gangrenosum of the orbit and the lacrimal sac.
    Cordero-Coma M; Pérez-Moreiras JV; Toribio A; Alonso-Orcajo N; Calleja S; Franco M; Ruiz de Morales JG
    Orbit; 2012 Aug; 31(4):249-51. PubMed ID: 22571540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.